Third-generation CARTs associated with promising clinical efficacy. »
07/22/23

Immunocoprecipitation experiment showed interaction between EGFR and TNNT2. »
07/22/23

MSS improved over both diagnostic periods (2001-2010 and 2011-2020) vs reference period 1990-2000 among men and women. »
03/18/23

Significant OM differences observed after stratification into targeted metastatic burden. »
07/04/23

For localised and most regional tumours, impact of other causes of death on total mortality increased with age. »
04/24/23

Combining FIT with risk factors for CRC did not increase yield of AN. »
12/02/22

RE cells generated significantly smaller tumours with suppressed inflammatory secretion profiles. »
07/24/22

Methylation status of MGMT promoter recognized as very powerful predictor of OS and PFS. »
06/01/23

Connection between RAD21, RAD50, BARD1 and ERBB2 and patient survival. »
04/06/23

High levels of hsa-miR-662 (miR-662) associated with future recurrence in bone. »
09/28/22